Aytu BioPharma (AYTU) Q2 2026 Earnings

13MayConfirmed
Q3 2025
Q4 2025
Q1 2026
Q2 2026
-2.93
-1.96
-1
-0.03

Details

Expected EPS
-0.443333
Actual EPS
-0.53
Surprise EPS
-0.09
Surprise Percent
+19.55%

Description

Aytu BioPharma (AYTU) has reported earnings of -0.53 per share for Q2 2026.

0 Comments

Share your thoughts